International Journal of Nanomedicine · 2017 · 45 citations · 49 references
Life SciencesBiochemistryNeuroscienceAnalytical ChemistryBiosensorsElectroanalytical MethodsAlzheimer DiseaseAmyloid FormationElectrochemical BiosensorsElectrochemical DetectionElectrochemical SensorsNanomaterial-based BiosensorsAmyloid Beta AggregationAmyloid Beta PeptidesColorimetric ScreeningElectrochemical MeasurementsElectrochemical SensingMethod Detection LimitNanoparticlesSilver Nanoparticle Biosensors
Soluble beta-amyloid (Aβ) oligomer is believed to be the most important toxic species in the brain of Alzheimer's disease (AD) patients. Thus, it is critical to develop a simple method for the selective detection of Aβ oligomer with low cost and high sensitivity. In this paper, we report an electrochemical method for the detection of Aβ oligomer with a peptide as the bioreceptor and silver nanoparticle (AgNP) aggregates as the redox reporters. This strategy is based on the conversion of AgNP-based colorimetric assay into electrochemical analysis. Specifically, the peptide immobilized on the electrode surface and presented in solution triggered together the in situ formation of AgNP aggregates, which produced a well-defined electrochemical signal. However, the specific binding of Aβ oligomer to the immobilized peptide prevented the in situ assembly of AgNPs. As a result, a poor electrochemical signal was observed. The detection limit of the method was found to be 6 pM. Furthermore, the amenability of this method for the analysis of Aβ oligomer in serum and artificial cerebrospinal fluid (aCSF) samples was demonstrated.
49
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Laurén, David A. Gimbel, Haakon B. Nygaard et al. · Nature · 2009 · 1.5K citations · Full text